Market Research Logo

The U.S. Market for Over-the-Counter Anti-Infectives

The U.S. Market for OTC anti-infective products surpassed the $2 billion mark last year. Although overall growth is sluggish, the market is a proven revenue source for a number of major brands, and there have been some nice surprises in the performance of some categories, such as first-aid related antiseptic and antibiotic products.

This comprehensive report examines all aspects of the U.S. OTC market, including 5-year sales performance by brand and by marketer for the following categories of products:

  • Antifungals
    • Jock-Itch Products
    • Vaginal Yeast Infection Products
    • Athlete’s Foot Products
  • Antiseptic/Antibiotics
  • Antiparasitics

The report also provides in-depth coverage consumer demographic and preferences and analyses of sales channels. Th competitive picture is extensively examined in terms of market share by player, market share by brand, promotional spend, new product development, and much more. Profiles of the top competitors round out the picture of the marketplace.

The methodology for assembling this report included a combination of primary and secondary research. Information Resources Inc. (IRI) and Simmons Market Research Bureau (SMRB) provided primary research findings; secondary research included such material as published reports, news stories, and company literature and documents.


  • Executive Summary
    • REPORT SCOPE
    • CATEGORIES
    • METHODOLOGY
    • PRODUCT DESCRIPTION
      • Overview
      • Antiseptics
      • Antibiotics
      • Antifungal Treatments
      • Anti-Parasitic (Lice) Treatments
    • THE MARKET
      • Table U.S. Retail OTC Anti-Infective Sales 2000-2005
    • MARKET COMPOSITION
      • Table IRI-Tracked Retail Anti-Infective Category Sales 2005
    • KEY TRENDS & ISSUES
      • Seasonality in Anti-fungal Treatment Sales
      • Most Drugs Approved in 2004 Since 1996
      • Lack of Rx-to-OTC Switches for Anti-infectives
      • Growing Healthcare Costs
    • THE ONLINE HEALTHCARE MARKET
      • The Growth of Generics
    • MARKET FORECAST
      • The Marketers
        • Table IRI-Tracked Retail Sales of U.S. Top 10 Anti-Infective Marketers 2004-2005
        • Table IRI-Tracked Retail Sales of U.S. Top 10 Anti-Infective Brands 2004-2005
      • Private Labels
    • THE CONSUMER
      • Marketing Dynamics
  • The Market
    • PRODUCT DESCRIPTION
      • Overview
      • Antiseptics
      • Antibiotics
      • Antibiotic Resistance
      • Antifungal Treatments
    • INTRODUCTION TO INFECTIONS
      • Jock Itch (Tinea Cruris)
      • Vaginal Yeast Infection (Vulvovaginal Candidiasis)
      • Athlete's Foot (Tinea Pedis)
      • Antiparasitic (Lice) Treatments
      • Regulatory Environment
      • Brand and Generic Names
      • The Cost Factor
      • Approval Process
        • Table Stages in Clinical Trial
    • OTC AND PRESCRIPTION DRUGS
    • RX-TO-OTC SWITCH
      • Labeling Issues
      • Industry Overview
      • Market Composition
      • Anti-fungal Treatment
        • Table IRI-Tracked U.S. Retail Sales of OTC Anti-Infectives by Category (Antifungals, First Aid, Antiparasitics) 2000-2005 (E)
        • Table IRI-Tracked U.S. Retail OTC Anti-Infective Category Shares 2000-2005 (E)
        • Table IRI-Tracked U.S. Retail Sales of OTC Antifungals by Infection Type (Athlete's Foot, Jock Itch, Vaginal Yeast Infection) 2000-2005 (E)
      • First Aid Products
      • Anti-Parasitic Treatments
    • KEY TRENDS & ISSUES
      • Seasonality in Antifungal Treatment Sales
        • Table U.S. Top 10 Cities Estimated to Experience Itch-Related Infections, 2005
      • Number of New Drug Approvals
      • More Botanicals, Fewer Preservatives
      • Lack of Rx-to-OTC Switches for Anti-Infectives
      • Growing Healthcare Costs
        • Table Projected U.S. Health Expenditures and Per Capita Income 2005-2010
      • Children - A Key Demographic
        • Table Younger U.S. Population (Under 15 Years) Projections (in thousands) 2000-2030
        • Table Birth Rate and Women Age Group, 2002-2003
      • Growing Insurer Share in Healthcare
      • Pharma's Revenue Expectations
      • Importation of Drugs
      • Growing Share of Uninsured Population
        • Table Uninsured Population by Age Group, 2003
      • Lower Drug Costs Through Outsourcing
      • Consumer Acceptance of Self-Medication
      • The Online Healthcare Market
      • The Insurer Push
      • Direct-to-Consumer Advertising
      • The Growth of Generics
        • Table U.S. Generic Drug vs. Branded Drug Performance
        • Table U.S. Top Five Generic Drug Marketers 2004 (Sales, Market Share, Growth from 2003)
    • MARKET FORECAST
      • Table U.S. Retail Anti-Infective Sales Projections by Category 2005-2010 (E)
  • The Marketers
    • COMPETITIVE ANALYSIS
      • Top Marketers and Products
        • Table IRI-Tracked Sales of Top 10 U.S. OTC Anti-Infective Marketers 2000-2005 (E)
        • Table IRI-Tracked Sales of Top 10 U.S. OTC Anti-Infective Brands 2000-2005 (E)
    • ANTIFUNGAL TREATMENTS
      • Table IRI-Tracked Sales of Top 10 U.S. OTC Antifungal Marketers 2000-2005 (E)
      • Table U.S. Top 10 Antifungal Marketers by Market Share 2000-2005 (E)
      • Table IRI-Tracked Sales of Top 10 U.S. OTC Antifungal Brands 2000-2005 (E)
      • Flat Sales for Jock Itch Brands
        • Table IRI-Tracked Sales of Top 10 U.S. OTC Jock Itch Treatment Marketers, 2000-2005 (E)
        • Table U.S. Top 10 OTC Jock Itch Treatment Marketers by Market Share, 2000-2005 (E)
        • Table IRI-Tracked Sales of Top 10 U.S. OTC Jock Itch Treatment Brands 2000-2005 (E)
      • Lotrimin Ultra Outperforms Category
        • Table Top 10 Recognized Dermatology Brands in North America, 2005
      • Monistat Dominates Yeast Infection Treatments
        • Table IRI-Tracked Sales of Top 10 U.S.OTC Vaginal Yeast Infection Treatment Marketers 2000-2005 (E)
        • Table U.S. Top 10 Vaginal Yeast Infection Treatment Marketers by Market Share, 2000-2005 (E)
        • Table IRI-Tracked Sales of Top 10 U.S. OTC Vaginal Yeast Infection Treatment Brands, 2000-2005 (E)
      • Athlete's Foot - Schering-Plough at the Top
        • Table IRI-Tracked Sales of Top 10 U.S. OTC Athlete's Foot Treatment Marketers, 2000-2005 (E)
        • Table U.S. Top 10 Athlete's Foot Treatment Marketers by Market Share, 2000-2005 (E)
        • Table IRI-Tracked Sales of Top 10 U.S. OTC Athlete's Foot Treatment Brands, 2000-2005 (E)
    • ANTISEPTICS/ANTIBIOTICS
      • First Aid Brands Thrive
        • Table IRI-Tracked Sales of Top 10 U.S. OTC Antiseptic/Antibiotic Marketers, 2000-2005 (E)
        • Table U.S. Top 10 Antiseptic/Antibiotic Marketers by Market Share, 20002005 (E)
        • Table IRI-Tracked Sales of Top 10 U.S. OTC Antiseptic/Antibiotic Brands, 2000-2005 (E)
    • ANTI-PARASITICS
      • Lice Treatments Suffer
        • Table IRI-Tracked Sales of Top 10 U.S. OTC Anti-Parasitic Treatment Marketers, 2000-2005 (E)
        • Table U.S. Top 10 Anti-Parasitic Treatment Marketers by Market Share 2000-2005 (E)
        • Table IRI-Tracked Sales of Top 10 U.S. OTC Anti-Parasitic Treatment Brands, 2000-2005 (E)
    • PRIVATE LABELS
      • Table IRI-Tracked Sales of U.S. Private Label OTC Anti-Infectives by Category (Antiseptics/Antibiotics, Anti-fungal Treatments, Antiparasitic Treatments) 2000-2005 (E)
      • Table U.S. Private Label OTC Anti-Infective Market Share by Category (Antiseptics/Antibiotics, Anti-fungal Treatments, Antiparasitic Treatments) 2000-2005 (E)
    • MERGERS & ACQUISITIONS
      • Pfizer Acquires Pharmacia Corp.
      • Novartis AG - Eon Labs
      • Novartis Acquires Vagistat from Bristol-Myers Squibb
      • Mylan Laboratories Acquires King Pharmaceuticals
  • The Consumer
    • SIMMONS SURVEY
    • OVERVIEW
    • FIRST AID
      • First Aid Bandages
        • Table U.S. Usage of First Aid Bandages by Age, 2005
        • Table U.S. Usage of First Aid Bandages, by Ethnicity, 2005
      • Sprays, Gels & Wipes Emerging
        • Table U.S. Usage of First Aid Sprays, Gels and Wipes by Household Size, 2005
        • Table U.S. Usage of First Aid Sprays, Gels and Wipes by Age of Children, 2005
      • Band-Aid, The Consumer's Favorite
        • Table Demographic Profile of U.S. First Aid Product Users, 2005
        • Table Demographic Profile of U.S. First Aid Cream, Gel and Liquid Users, 2005
        • Table Demographic Profile of U.S. First Aid Ointment, Spray, Stick and Wipe Users, 2005
        • Table Demographic Profile of U.S. First Aid Users by Brand, 2005
        • Table Demographic Profile of U.S. First Aid Users by Brand, 2005
        • Table Demographic Profile of U.S. First Aid Users by Brand, 2005
        • Table Demographic Profile of U.S. First Aid Users by Brand, 2005
        • Table Demographic Profile of U.S. First Aid Users by Brand, 2005
        • Table Demographic Profile of U.S. First Aid Users by Brand, 2005
        • Table Demographic Profile of U.S. First Aid Users by Brand, 2005
        • Table Demographic Profile of U.S. Store Brand First Aid Product Users, 2005
    • ANTIFUNGAL TREATMENTS
      • Foot and Nail Fungus
        • Table U.S. Prevalence of Athlete's Foot by Age, 2005
        • Table U.S. Prevalence of Athlete's Foot and Nail Fungus by Ethnicity, 2005
        • Table U.S. Prevalence of Athlete's Foot and Nail Fungus by Region, 2005
        • Table U.S. Prevalence of Athlete's Foot and Nail Fungus by Education, 2005
        • Table U.S. Foot Problem Prevalence, 2004
        • Table Demographic Profile of U.S. Athlete's Foot Treatment User, 2005
        • Table Demographic Profile of U.S. Nail Fungus Treatment User, 2005
        • Table Demographic Profile of U.S. Athlete's Foot-Infected Consumer, 2005
        • Table Demographic Profile of U.S. Nail Fungus-Infected Consumer, 2005
      • Yeast Infection
        • Table Demographic Profile of U.S. Women Using Yeast Infection Products, 2005
        • Table Yeast Infection Treatment by Type Preferred (1, 3, and 7-Day) 2005
        • Table Yeast Infection Treatment Usage by Ethnicity, 2005
        • Table Demographic Profile of U.S. Yeast Infection Treatment User by Treatment Type, 2005
        • Table Demographic Profile of U.S. Yeast Infection Treatment User by Brand, 2005
        • Table Demographic Profile of U.S. Yeast Infection Treatment User by Brand, 2005
        • Table Demographic Profile of U.S. Yeast Infection Treatment User by Brand, 2005
    • CONSUMER ATTITUDES
      • Preference for OTC Drugs and Private Labels
        • Table U.S. Consumer Attitudes w.r.t. Healthcare and Drugs, 2005
      • Store Brand Buyers
        • Table Demographic Profile of U.S. Consumers Based on Attitude Towards Store Brands, 2004
  • Marketing Dynamics
    • OVERVIEW
    • ADVERTISING AND PROMOTION
      • Pfizer Tops Ad Spend List
        • Table Ad Spend of Top 10 U.S. OTC Anti-Infective Marketers 2004
        • Table Ad Spend and Media Channel of Top 10 U.S. OTC Anti-Infective Brands 2004
      • Novartis' DTC Campaign
      • Monistat Intimate Skincare Launch
    • DISTRIBUTION & RETAILING
      • Drug Store Chains
      • e-Pharmacies
    • RETAIL TRENDS
      • Drug Stores Outpace Overall Market
        • Table U.S. Sales of Select OTC Anti-Infective Categories Through Drug Stores 2004
    • STORE CLINICS
      • Rite Aid Tests Hispanic Stores
      • Drug Chains Aid Consumers
      • Pharmacy Recommendations
        • Table Top Pharmacist Recommended Adhesive Bandages, 2005
        • Table Top Pharmacist Recommended Athlete's Foot Treatments, 2005
        • Table Top Pharmacist Recommended Jock Itch Treatments, 2005
        • Table Top Pharmacist Recommended Lice Treatments, 2005
        • Table Top Pharmacist Recommended Nail Fungus Treatments, 2005
        • Table Top Pharmacist Recommended Scar Treatments, 2005
        • Table Top Pharmacist Recommended Vaginal Antifungals, 2005
        • Table Top Pharmacist Recommended Wound Treatments, 2005
      • Walgreens' Health Initiatives
    • NEW PRODUCT INTRODUCTIONS
      • Table Top 10 Marketers by Total SKUs Launched, 2005
      • Table Top 10 Brands by Total SKUs Launched, 2005
      • Consumers Prefer Quick-Relief & Natural Products
        • Table Top 10 Package Tags by Number of Brands, 2005
        • Table U.S. Anti-Infective Product Introductions Tagged `Instant/Quick', 2005
        • Table U.S. Anti-Infective Product Introductions Tagged `Natural/Pure/Organic*', 2005
      • First Aid for Kids
        • Table U.S. Anti-Infective Product Introductions for Teens/Kids, 2005
        • Table U.S. Anti-Infective Product Introductions Tagged `Upscale', 2005
      • Limited Yeast Infection Products
        • Table U.S. Anti-Infective Product Introductions for Women, 2005
      • Hypoallergenic Anti-Infectives
        • Table U.S. Anti-Infective Product Introductions Tagged `No Allergy', 2005
        • Table U.S. Anti-Infective Product Introductions Tagged `High Vitamins', 2005
      • Scented/Flavored Products
        • Table Top 10 OTC Anti-Infective Flavors/Fragrances, 2005
        • Table U.S. Anti-Infective Product Introductions Flavored/Scented `Blend', 2005
        • Table U.S. Anti-Infective Product Introductions Flavored/Scented `Lavender', 2005
    • INNOVATION
      • Curad Bandages
        • Table U.S. Anti-Infective Product Introductions by Innovation, 2005
  • Company Profiles
    • JOHNSON & JOHNSON
      • Overview
      • OTC Anti-Infective Product Line
        • Table Johnson & Johnson OTC Anti-Infective Brand Portfolio
    • PFIZER INC.
      • Overview
      • OTC Anti-Infective Product Line
        • Table Pfizer Inc. OTC Anti-infective Brand Portfolio
      • Focus on Pharmaceuticals and Healthcare
    • BAYER GROUP
      • Overview
      • U.S. Operations
      • OTC Anti-Infective Product Line
        • Table Bayer OTC Anti-infective Brand Portfolio
      • Bayer, Expanding its Reach
    • BRISTOL-MYERS SQUIBB COMPANY
      • Overview
      • OTC Anti-Infectives
      • Renewed Strategy - Focus on Prescription Drugs
    • NOVARTIS AG
      • Overview
      • The Consumer Health Division
      • OTC Anti-Infective Product Line
        • Table Novartis AG OTC Anti-infective Brand Portfolio
      • R&D: The Company's Lifeblood
    • SCHERING PLOUGH CORPORATION
      • Overview
      • OTC Anti-Infective Product Line
        • Table Bayer Anti-infective Brand Portfolio
    • COMBE INC.
      • Overview
      • OTC Anti-Infective Product line
        • Table Combe Inc. OTC Anti-infective Brand Portfolio
    • CHATTEM INC.
      • Overview
      • OTC Anti-Infective Product Line
    • PERFORMANCE
      • Future Strategy
    • MERZ PHARMACEUTICALS
      • Overview
      • Performance
    • BEIERSDORF AG
      • Overview
      • OTC Anti-Infective Product Line
        • Table Beiersdorf Inc. OTC Anti-infective Brand Portfolio
      • Future Strategy
    • TARO PHARMACEUTICALS INDUSTRIES LTD.
      • Overview
      • R&D
      • Drug Portfolio
      • FDA Approves Taro's Mupirocin Ointment
    • STIEFEL LABORATORIES INC.
      • Overview
      • Skin Care Products
      • Sarna #1 Itch Relief Cream for 3 Years
      • FDA Approval for MimyX Cream
    • ALVA-AMCO PHARMACAL COMPANIES INC.
      • Overview
      • Product Portfolio
      • FungiCure 2004 Nail Hygiene Survey
    • BECTON DICKINSON & COMPANY
      • Overview
      • Anti-Infective Products
        • Table Becton Dickinson Company Sales, by Region, 2004 (in billion $)
        • Table Becton Dickinson Company Sales, by Division, 2004 (in million $)
      • FDA Approval for BD Diagnostic Products
    • PLAYTEX PRODUCTS INC.
      • Overview
      • Product Portfolio
        • Table Playtex Products Inc. Sales, by Division, 2004 (in million $)
      • Core Category Acquisitions
  • Addresses of Select Marketers

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report